Dr. Rosalyn Ortiz-Manso, MD

Dr. Ortiz-Manso practices at Broward Health Imperial Point in Fort Lauderdale, Florida, part of North Broward Hospital District.

Dr. Ortiz-Manso's NPI, 1285121996, was assigned on April 18, 2018. Dr. Ortiz-Manso graduated from San Juan Bautista School of Medicine in 2018. Dr. Ortiz-Manso holds Florida license ME149576.

Dr. Ortiz-Manso's primary practice is Broward Health Imperial Point, at 6401 N Federal Hwy, Fort Lauderdale, FL 33308 in Broward County. The practice phone is (954) 776-8500.

Dr. Ortiz-Manso's primary practice is Broward Health Imperial Point in Fort Lauderdale, Florida, part of North Broward Hospital District. Dr. Ortiz-Manso is also affiliated with Broward Health Coral Springs. The medical group on file is Eastside Hospitalists. Dmand AI also links Dr. Ortiz-Manso to 3 more medical groups and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ortiz-Manso practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Ortiz-Manso's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Ortiz-Manso is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Ortiz-Manso's licenses on file in 2 states: Florida and Texas.

Dmand AI lists acute diabetes, acute respiratory failure, anemia, aneurysm, arthritis, cardiac arrhythmia, cellulitis and chronic hypertension among the conditions Dr. Ortiz-Manso treats.

CMS data shows 792 Medicare services from Dr. Ortiz-Manso across 6 procedure codes in 2024, for 275 Medicare patients. Medicare paid $75,484 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 275 Medicare patients who saw Dr. Ortiz-Manso in 2024. The largest group is 65 to 74, with 89 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ortiz-Manso's median patient age at 71, with 44% women.

In 2024, Dr. Ortiz-Manso wrote 655 Medicare Part D claims for 300 patients. 89% of them were for generic drugs. CMS names the drug for 331 of them, across 18 drugs with 11 or more claims each, at $12,994 in total drug cost. In 2023, CMS named 85 claims across 6 drugs.

Dr. Ortiz-Manso accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Ortiz-Manso in 2021. Dr. Ortiz-Manso's most frequent co-authors are Hao T. Nguyen, MD and Kelvin Yohanes Soewono, DO.

CMS Open Payments shows 18 general payments to Dr. Ortiz-Manso from 7 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Inari Medical, Inc. paid the most, $926.

Dr. Ortiz-Manso graduated from San Juan Bautista School of Medicine in 2018.

Dr. Ortiz-Manso is in network with 4 carriers, including Aetna, United Healthcare and CMS Medicare. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.